Monthey Resident

GaDia

Developing an innovative, patented rapid in vitro diagnostic (IVD) test to detect nosocomial diseases. More specifically, the aim is to develop a new rapid Point-Of-Care (POC) predictive diagnostic test to discriminate healthcare-acquired fungal infections from other causes of infections.

IHMA Europe Sàrl

Leading provider of antimicrobial drug development support services for clients around the world. IHMA provides a full suite of technical capabilities and domain expertise in all phases of antimicrobial drug development: drug discovery, clinical development, regulatory approval and commercialization.

ImmunSkills SA

ImmunSkills SA is a company active in the field of cell therapy. Its objective is to improve the effectiveness of treatments for solid cancers by developing a new product based on allogenic cells.

AlphaOnco Swiss SA

AlphaOnco Swiss, subsidiary of Nanobacterie, is developing a cancer treatment using natural iron oxide nano-minerals, called magnetosomes, which are introduced to tumors and heated using various excitation sources (laser, ultrasound, magnetic field).

ASSCO Engineering Monthey SA

As a neutral, independent partner, ASSCO Engineering plans and realizes pharmaceutical and/or sterile production facilities in compliance with GMP guidelines and the requirements of inspection bodies active in the pharmaceutical and medical industries.

Scroll to Top